# Merck: portfolio, investments and team > Merck is an accelerator based in Germany. 8 investments on record, latest Sept 2015. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/merck-accelerator (Millionrounds; every figure on the page links to its filing or article) Germany · [Investor](https://millionrounds.com/investors) # Merck Last cheque observed Sep 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Accelerator Grant Growth Seed Biotechnology Health Care Life Science Cheques on record **0%** of best year **0** **cheques in 12 months**, 8 on record Since the last cheque **4053** days **00** hrs **00** min **00** sec Median round **$15M** Rounds led **0 of 8** Sole investor **1 rounds** Exits **1 from the portfolio** Mostly in **United States, 100%** Pitch Merck ## Merck highlights - 01 8 rounds on record - 02 Mostly Series B and Series D: 50% of its rounds - 03 Sole investor in 1 rounds, median $3.0M - 04 1 exits from the portfolio ## What they do - **Type:** Accelerator (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Grant Growth Seed Series A - **Sectors:** Biotechnology Health Care Life Science - **Based in:** Darmstadt, Germany - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **8 appearances** - **2015** 1 round - **Sept** **[Just. Biotherapeutics](https://millionrounds.com/company/just-biotherapeutics)** Series A · US **$15M** With 2 others - **2011** 2 rounds - **Feb** **[HTG Molecular Diagnostics](https://millionrounds.com/company/htg-molecular-diagnostics)** Series D · US · finsmes.com **$16M** With 3 others - **Feb** **[High Throughput Genomics](https://millionrounds.com/company/high-throughput-genomics)** Series D · US · htgenomics.com **$16M** With 4 others - **2008** 1 round - **Apr** **[VisEn Medical](https://millionrounds.com/company/visen-medical)** Series B · US **$5.0M** With 3 others - **2007** 1 round - **Oct** **[High Throughput Genomics](https://millionrounds.com/company/high-throughput-genomics)** Series C · US **$10M** With 3 others - **2003** 2 rounds - **Jul** **[ImpactRx](https://millionrounds.com/company/impactrx)** Venture · US **$3.0M** Sole investor - **Jul** **[Alnylam Pharmaceuticals](https://millionrounds.com/company/alnylam-pharmaceuticals)** Venture · US **$25M** With 4 others - **2001** 1 round - **Mar** **[Acurian](https://millionrounds.com/company/acurian)** Series B · US **$27M** With 1 other An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## Exits from the portfolio Companies it backed that were later bought or listed **1 in all** **[ImpactRx](https://millionrounds.com/company/impactrx)** Bought by [Symphony Technology Group](https://millionrounds.com/fund/symphony-technology-group) **Undisclosed** Apr 2011 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Grant Growth Seed Median round joined **$15M** the round, not its cheque Alone, median **$3.0M** Led 0 of 8 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** Sept 2015 - **Exits:** 1 from the portfolio Rounds by stage said on their site - Series B *2* - Series D *2* - Venture *2* - Series A said *1* - Series C *1* - Grant said *-* - Growth said *-* Cheques by year Led Joined 2001 2015 Often in the room with - [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 2 - [Fletcher Spaght, Inc.](https://millionrounds.com/fund/fletcher-spaght-inc) 2 - [Novo Holdings A/S](https://millionrounds.com/fund/novo-holdings-a-s) 2 - [Sol Cap Inc](https://millionrounds.com/fund/sol-cap-inc) 2 - [Valley Ventures](https://millionrounds.com/fund/valley-ventures) 2 **Pitching Merck?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Merck. A count of rooms they were both in, not a relationship either has claimed. [**ARCH Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Fletcher Spaght, Inc.** VC firm **2** rounds together](https://millionrounds.com/fund/fletcher-spaght-inc)[**Novo Holdings A/S** Growth equity **2** rounds together](https://millionrounds.com/fund/novo-holdings-a-s)[**Sol Cap Inc** Growth equity **2** rounds together](https://millionrounds.com/fund/sol-cap-inc)[**Valley Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/valley-ventures) ## Quick answers about Merck ### What does Merck invest in? Merck invests most often at Series B and Series D (50% of the rounds on record), in sectors such as Biotechnology, Health Care and Life Science. ### How active is Merck? 8 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2015. ### How big are Merck's cheques? The median round it joins is $15M. ### Does Merck lead rounds? Rarely, if at all: none of its 8 investments on record names it as the lead. ### Where does Merck invest? Most of the companies it backs are in the United States (100%). ### Is Merck investing now? No investments in the last 12 months; the latest was in Sept 2015. ### Who does Merck invest alongside? Most often ARCH Venture Partners (2 rounds together), Fletcher Spaght, Inc. (2 rounds together) and Novo Holdings A/S (2 rounds together). ### What kind of investor is Merck? Merck is an accelerator based in Darmstadt, Germany. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=merck-accelerator) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=merck-accelerator)